Mott David M
Novavax, Inc. · Director
Mott David M is listed in public filings as director. This Mott David M insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Novavax, Inc. (NVAX), Ardelyx, Inc. (ARDX), and Adaptimmune Therapeutics plc (ADAPY). Investors use Mott David M's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| $997k215.9k shares | BuyNov 13, 2024 | $4.62 | -- | |
| $997k213.3k shares | BuyDec 19, 2024 | $4.67 | -- | |
| $993k199k shares | BuyJan 21, 2025 | $4.99 | -- | |
| $389k77.7k shares | BuyFeb 24, 2025 | $5.00 | -- | |
| $1.6M381.4k shares | BuyMay 2, 2025 | $4.22 | -- | |
| $329k100k shares | BuyMay 15, 2025 | $3.29 | -- | |
| $737k200k shares | BuyJun 9, 2025 | $3.69 | -- | |
| $726k200k shares | BuyJun 16, 2025 | $3.63 | -- |